top of page

Performance Physical Therapy Announces New Independent Director Appointment to Board


Contact: Dr. Michelle Collie PT, DPT, MS


Providence, RI, April 13, 2022 - Performance Physical Therapy, a leading New England-based physical therapy platform helping patients of all ages achieve optimal physical function – fitness, wellness, and rehabilitation – announces the appointment of Sharon Dunn as a new independent Board Member.

Sharon Dunn, PT, PhD, is the dean of the School of Allied Health Professions and a professor of rehabilitation sciences at Lousiana State University Shreveport. Sharon just completed her second term as the American Physical Therapy Association’s (“APTA”) president and is a board-certified clinical specialist in orthopedic physical therapy. She has been instrumental in previous leadership roles including being a director on APTA’s board, serving as president of the Louisiana Physical Therapy Association, and director of the Orthopaedic Physical Therapy Residency for Lousiana State University Health Shreveport. She is also a former recipient of the Allen A. Copping Excellence in Teaching Award, a nationally invited keynote speaker, a peer-reviewed publisher of numerous scientific articles, and one of the most well-regarded thought leaders in the physical therapy industry.

Dunn joins Michelle Collie, Performance founder and CEO, and Nancy Phillips, Rallyday co-founder and managing partner, to continue to drive Performance’s vision to empower people to feel better, move freely, and live fully. The positive impact the appointment of Dunn will have on the Company’s strategic vision is extensive. She brings with her thought partnership and insight to the practice that the Performance Board looks forward to integrating and building on. “Performance is here to challenge the status quo of what healthcare can offer a community and teach the community that physical therapy is much more about health and living life than just managing an injury, disability, or illness,” says Performance CEO and founder Michelle Collie. “We can lead the way in showing the world a better, faster, more cost-effective, more efficient way of treating conditions that affect how people move through the world and we know Sharon will be a crucial piece in helping us reach these goals.”

“In today’s health delivery systems, providers